IMbrave150: Atezolizumab plus Bevacizumab in HCC: Efficacy Data and Clinical Practice Implications : Episode 8
Advanced HCC: Key Takeaways
Key opinion leaders summarize essential takeaways and highlight unmet needs in the hepatocellular carcinoma treatment landscape.
Video content above is prompted by the following:
- What are some key takeaways from this analysis?
- What are some clinical pearls you wish to offer your community colleagues who are considering treating their patients with atezo + bev? (EGD consideration, etc)
- What are some unmet needs in the treatment of advanced HCC?
Recent Videos
Related Content
